| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Mage3/Heat Shock Protein70 DNA vaccine induces both innate and adaptive immune responses for the antitumor activity
|
Wang, Lifeng
|
|
2009
|
28 |
2 |
p. 561-570
10 p.
|
artikel
|
| 2 |
A novel form of 4-1BBL has better immunomodulatory activity than an agonistic anti-4-1BB Ab without Ab-associated severe toxicity
|
Schabowsky, Rich-Henry
|
|
2009
|
28 |
2 |
p. 512-522
11 p.
|
artikel
|
| 3 |
Anti-preS responses influence the anti-HBs response in newborns after vaccination with the third generation Sci-B-Vac™ vaccine
|
Sylvan, Staffan P.E.
|
|
2009
|
28 |
2 |
p. 446-451
6 p.
|
artikel
|
| 4 |
A practical in vitro growth inhibition assay for the evaluation of TB vaccines
|
Kolibab, Kristopher
|
|
2009
|
28 |
2 |
p. 317-322
6 p.
|
artikel
|
| 5 |
CD4+ T-cell responses to an oral inactivated cholera vaccine in young children in a cholera endemic country and the enhancing effect of zinc supplementation
|
Ahmed, Tanvir
|
|
2009
|
28 |
2 |
p. 422-429
8 p.
|
artikel
|
| 6 |
Characterization and antigenicity of the promising vaccine candidate Plasmodium vivax 34kDa rhoptry antigen (Pv34)
|
Mongui, Alvaro
|
|
2009
|
28 |
2 |
p. 415-421
7 p.
|
artikel
|
| 7 |
Comparative immunogenicity of recombinant influenza hemagglutinin (rHA) and trivalent inactivated vaccine (TIV) among persons ≥65 years old
|
Keitel, W.A.
|
|
2009
|
28 |
2 |
p. 379-385
7 p.
|
artikel
|
| 8 |
Comparison of monocyte-derived dendritic cells from colorectal cancer patients, non-small-cell-lung-cancer patients and healthy donors
|
Kvistborg, P.
|
|
2009
|
28 |
2 |
p. 542-547
6 p.
|
artikel
|
| 9 |
Construction of a triple modified p53 containing DNA vaccine to enhance processing and presentation of the p53 antigen
|
Hospers, Geke A.P.
|
|
2009
|
28 |
2 |
p. 386-391
6 p.
|
artikel
|
| 10 |
Curcumin! Spicy panacea for all—Friend or foe
|
Marathe, Sandhya
|
|
2009
|
28 |
2 |
p. 291-292
2 p.
|
artikel
|
| 11 |
Development of a simple and high-yielding fed-batch process for the production of influenza vaccines
|
Meghrous, Jamal
|
|
2009
|
28 |
2 |
p. 309-316
8 p.
|
artikel
|
| 12 |
Differential maternal responses to a newly developed vaccine information pamphlet
|
Klein, Nicola P.
|
|
2009
|
28 |
2 |
p. 323-328
6 p.
|
artikel
|
| 13 |
Editorial Board
|
|
|
2009
|
28 |
2 |
p. CO2-
1 p.
|
artikel
|
| 14 |
Elicitation of broad CTL response against HIV-1 by the DNA vaccine encoding artificial multi-component fusion protein MultiHIV—Study in domestic pigs
|
Mölder, Tarmo
|
|
2009
|
28 |
2 |
p. 293-298
6 p.
|
artikel
|
| 15 |
Enhancement of in vivo and in vitro immune functions by a conformationally biased, response-selective agonist of human C5a: Implications for a novel adjuvant in vaccine design
|
Morgan, Edward L.
|
|
2009
|
28 |
2 |
p. 463-469
7 p.
|
artikel
|
| 16 |
Evaluation of serological trials submitted for annual re-licensure of influenza vaccines to regulatory authorities between 1992 and 2002
|
Voordouw, A.C.G.
|
|
2009
|
28 |
2 |
p. 392-397
6 p.
|
artikel
|
| 17 |
Evaluation of the safety and immunogenicity of Plasmodium falciparum apical membrane antigen 1, merozoite surface protein 1 or RTS,S vaccines with adjuvant system AS02A administered alone or concurrently in rhesus monkeys
|
Pichyangkul, S.
|
|
2009
|
28 |
2 |
p. 452-462
11 p.
|
artikel
|
| 18 |
Further development of raccoon poxvirus-vectored vaccines against plague (Yersinia pestis)
|
Rocke, Tonie E.
|
|
2009
|
28 |
2 |
p. 338-344
7 p.
|
artikel
|
| 19 |
Heterologous prime boost vaccination with DNA and recombinant modified vaccinia virus Ankara protects IFNAR(−/−) mice against lethal bluetongue infection
|
Calvo-Pinilla, Eva
|
|
2009
|
28 |
2 |
p. 437-445
9 p.
|
artikel
|
| 20 |
Identification of new meningococcal serogroup B surface antigens through a systematic analysis of neisserial genomes
|
Pajon, Rolando
|
|
2009
|
28 |
2 |
p. 532-541
10 p.
|
artikel
|
| 21 |
Improving the expression of recombinant soluble HIV Envelope glycoproteins using pseudo-stable transient transfection
|
Sellhorn, George
|
|
2009
|
28 |
2 |
p. 430-436
7 p.
|
artikel
|
| 22 |
Induction of mucosal and systemic antibody responses against the HIV coreceptor CCR5 upon intramuscular immunization and aerosol delivery of a virus-like particle based vaccine
|
Hunter, Zoe
|
|
2009
|
28 |
2 |
p. 403-414
12 p.
|
artikel
|
| 23 |
Joint reviews and inspections: Strategic forms of collaboration for strengthening the regulatory oversight of vaccine clinical trials in Africa
|
Maïga, Diadié
|
|
2009
|
28 |
2 |
p. 571-575
5 p.
|
artikel
|
| 24 |
Liposomal gD ectodomain (gD1–306) vaccine protects against HSV2 genital or rectal infection of female and male mice
|
Olson, K.
|
|
2009
|
28 |
2 |
p. 548-560
13 p.
|
artikel
|
| 25 |
Memory B and T cell responses induced by serotype 4 Streptococcus pneumoniae vaccines: Longitudinal analysis comparing responses elicited by free polysaccharide, conjugate and carrier
|
Deauvieau, Florence
|
|
2009
|
28 |
2 |
p. 576-582
7 p.
|
artikel
|
| 26 |
Modulation of inter-vaccination interval to avoid antigenic competition in multivalent footrot (Dichelobacter nodosus) vaccines in sheep
|
Dhungyel, Om P.
|
|
2009
|
28 |
2 |
p. 470-473
4 p.
|
artikel
|
| 27 |
Molecular smallpox vaccine delivered by alphavirus replicons elicits protective immunity in mice and non-human primates
|
Hooper, Jay W.
|
|
2009
|
28 |
2 |
p. 494-511
18 p.
|
artikel
|
| 28 |
National influenza surveillance in Vietnam, 2006–2007
|
Nguyen, Hien T.
|
|
2009
|
28 |
2 |
p. 398-402
5 p.
|
artikel
|
| 29 |
Ovine atadenovirus, a novel and highly immunogenic vector in prime-boost studies of a candidate HIV-1 vaccine
|
Bridgeman, Anne
|
|
2009
|
28 |
2 |
p. 474-483
10 p.
|
artikel
|
| 30 |
Preputial cellular and antibody responses of bulls vaccinated and/or challenged with Tritrichomonas foetus
|
Cobo, Eduardo R.
|
|
2009
|
28 |
2 |
p. 361-370
10 p.
|
artikel
|
| 31 |
Rabies virus-based vaccines elicit neutralizing antibodies, poly-functional CD8+ T cell, and protect rhesus macaques from AIDS-like disease after SIVmac251 challenge
|
Faul, Elizabeth J.
|
|
2009
|
28 |
2 |
p. 299-308
10 p.
|
artikel
|
| 32 |
Randomized, double-blind, Phase 1 trial of an alphavirus replicon vaccine for cytomegalovirus in CMV seronegative adult volunteers
|
Bernstein, David I.
|
|
2009
|
28 |
2 |
p. 484-493
10 p.
|
artikel
|
| 33 |
RotaTeq®, a pentavalent rotavirus vaccine: Efficacy and safety among infants in Europe
|
Vesikari, Timo
|
|
2009
|
28 |
2 |
p. 345-351
7 p.
|
artikel
|
| 34 |
Safety and immunogenicity of a defined vaccine for the prevention of cutaneous leishmaniasis
|
Vélez, Iván D.
|
|
2009
|
28 |
2 |
p. 329-337
9 p.
|
artikel
|
| 35 |
Swine influenza matrix 2 (M2) protein contributes to protection against infection with different H1 swine influenza virus (SIV) isolates
|
Kitikoon, Pravina
|
|
2009
|
28 |
2 |
p. 523-531
9 p.
|
artikel
|
| 36 |
The preventive phase I trial with the HIV-1 Tat-based vaccine
|
Ensoli, Barbara
|
|
2009
|
28 |
2 |
p. 371-378
8 p.
|
artikel
|
| 37 |
The use of immune complex vaccines to enhance antibody responses against neutralizing epitopes on HIV-1 envelope gp120
|
Hioe, Catarina E.
|
|
2009
|
28 |
2 |
p. 352-360
9 p.
|
artikel
|
Tijdschrift beschrijving